{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:50:19Z","timestamp":1792021819204,"version":"4.4.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:00:00Z","timestamp":1782777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000233","name":"Genome British Columbia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000233","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Advances"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/j.jacadv.2026.103053","type":"journal-article","created":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T20:54:23Z","timestamp":1786136063000},"page":"103053","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Opportunistic Genetic Testing for Familial Hypercholesterolemia in Premature Acute Coronary Syndrome"],"prefix":"10.1016","volume":"5","author":[{"given":"Nicol","family":"Vaizman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lubomira","family":"Cermakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam I.","family":"Kramer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle","family":"Hui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda M.","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Roston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.B. John","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher B.","family":"Fordyce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iulia","family":"Iatan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3686-3807","authenticated-orcid":false,"given":"Liam R.","family":"Brunham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jacadv.2026.103053_bib1","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.jacc.2018.05.044","article-title":"Clinical genetic testing for familial hypercholesterolemia: JACC scientific expert panel","volume":"72","author":"Sturm","year":"2018","journal-title":"J Am Coll Cardiol"},{"issue":"20","key":"10.1016\/j.jacadv.2026.103053_bib2","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1016\/j.jacc.2020.03.057","article-title":"Worldwide prevalence of familial hypercholesterolemia: meta-analyses of 11 million subjects","volume":"75","author":"Beheshti","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"45","key":"10.1016\/j.jacadv.2026.103053_bib3","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.jacadv.2026.103053_bib4","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1210\/jc.2012-1563","article-title":"Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication","volume":"97","author":"Benn","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"issue":"10","key":"10.1016\/j.jacadv.2026.103053_bib5","first-page":"1322","article-title":"Estimating the prevalence of familial hypercholesterolemia in acute coronary syndrome: a systematic review and meta-analysis","volume":"35","author":"Kramer","year":"2019","journal-title":"Can J Cardiol"},{"issue":"4","key":"10.1016\/j.jacadv.2026.103053_bib6","doi-asserted-by":"crossref","first-page":"E754","DOI":"10.9778\/cmajo.20220108","article-title":"Genetic testing for familial hypercholesterolemia in Quebec, Canada: a single-centre retrospective cohort study","volume":"11","author":"Guerin","year":"2023","journal-title":"CMAJ Open"},{"issue":"24","key":"10.1016\/j.jacadv.2026.103053_bib7","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/j.jacc.2023.09.828","article-title":"Research priorities in critical care cardiology: JACC expert panel","volume":"82","author":"Miller","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.103053_bib8","article-title":"The design and rationale of the advancing cardiac care unit-based rapid assessment and treatment of hypErcholesterolemia (ACCURATE) study","volume":"13","author":"Peng","year":"2022","journal-title":"Am Heart J Plus"},{"issue":"7","key":"10.1016\/j.jacadv.2026.103053_bib9","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1002\/clc.22959","article-title":"The design and rationale of SAVE BC: the study to avoid CardioVascular events in British Columbia","volume":"41","author":"Brunham","year":"2018","journal-title":"Clin Cardiol"},{"issue":"2","key":"10.1016\/j.jacadv.2026.103053_bib10","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1093\/clinchem\/hvad190","article-title":"The Sampson-NIH equation is the preferred calculation method for LDL-C","volume":"70","author":"Sampson","year":"2024","journal-title":"Clinical Chemistry"},{"issue":"2","key":"10.1016\/j.jacadv.2026.103053_bib11","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1373\/clinchem.2017.279422","article-title":"Imputation of baseline LDL cholesterol concentration in patients with familial hypercholesterolemia on statins or ezetimibe","volume":"64","author":"Ruel","year":"2018","journal-title":"Clin Chem"},{"issue":"2","key":"10.1016\/j.jacadv.2026.103053_bib12","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.gim.2021.09.012","article-title":"The Clinical Genome resource (ClinGen) Familial hypercholesterolemia variant curation expert panel consensus guidelines for LDLR variant classification","volume":"24","author":"Chora","year":"2022","journal-title":"Genet Med"},{"issue":"5","key":"10.1016\/j.jacadv.2026.103053_bib13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"issue":"14","key":"10.1016\/j.jacadv.2026.103053_bib14","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1016\/j.jacc.2017.08.009","article-title":"Genetically confirmed familial hypercholesterolemia in patients with acute coronary syndrome","volume":"70","author":"Amor-Salamanca","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.103053_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2024.1433042","article-title":"Genetic testing for familial hypercholesterolemia in a Finnish cohort of patients with premature coronary artery disease and elevated LDL-C levels","volume":"11","author":"Jokiniitty","year":"2024","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/j.jacadv.2026.103053_bib16","doi-asserted-by":"crossref","first-page":"71","DOI":"10.2147\/TACG.S202942","article-title":"High prevalence of genetic determined familial hypercholesterolemia in premature coronary artery disease","volume":"12","author":"Pirazzi","year":"2019","journal-title":"Appl Clin Genet"},{"issue":"1","key":"10.1016\/j.jacadv.2026.103053_bib17","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1186\/s40246-025-00769-y","article-title":"Correlation between clinical classification and genetic analysis of familial hypercholesterolemia in premature coronary artery disease in a cohort of Egyptian patients","volume":"19","author":"Zahwo","year":"2025","journal-title":"Human Genomics"},{"key":"10.1016\/j.jacadv.2026.103053_bib18","article-title":"Prevalence and prognosis of molecularly defined familial hypercholesterolemia in patients with acute coronary syndrome","volume":"9","author":"Wang","year":"2022","journal-title":"Front Cardiovasc Med"},{"issue":"3","key":"10.1016\/j.jacadv.2026.103053_bib19","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.jacl.2020.04.002","article-title":"Prevalence of genetically verified familial hypercholesterolemia among young (<45 years) Norwegian patients hospitalized with acute myocardial infarction","volume":"14","author":"Bogsrud","year":"2020","journal-title":"J Clin Lipidol"},{"issue":"39","key":"10.1016\/j.jacadv.2026.103053_bib20","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000039939","article-title":"Prevalence of genetically diagnosed familial hypercholesterolemia in Vietnamese patients with premature acute myocardial infarction","volume":"103","author":"Nguyen","year":"2024","journal-title":"Medicine"},{"issue":"3","key":"10.1016\/j.jacadv.2026.103053_bib21","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1002\/clc.23154","article-title":"Prevalence of familial hypercholesterolemia in patients with premature myocardial infarction","volume":"42","author":"Cui","year":"2019","journal-title":"Clin Cardiol"},{"issue":"2","key":"10.1016\/j.jacadv.2026.103053_bib22","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ejim.2015.01.014","article-title":"Prevalence of DNA-confirmed familial hypercholesterolaemia in young patients with myocardial infarction","volume":"26","author":"Wald","year":"2015","journal-title":"Eur J Intern Med"},{"issue":"11","key":"10.1016\/j.jacadv.2026.103053_bib23","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.3390\/jcm9113489","article-title":"Familial hypercholesterolemia in premature acute coronary syndrome. Insights from CholeSTEMI registry","volume":"9","author":"Lorca","year":"2020","journal-title":"J Clin Med"},{"issue":"34","key":"10.1016\/j.jacadv.2026.103053_bib24","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"issue":"22","key":"10.1016\/j.jacadv.2026.103053_bib25","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1016\/j.jacc.2024.11.009","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"85","author":"Rao","year":"2025","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.103053_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijcard.2024.132916","article-title":"Inadequate Intensification of LDL-cholesterol lowering therapy after coronary revascularization: insights from the GOULD registry","volume":"421","author":"Peterson","year":"2025","journal-title":"Int J Cardiol"},{"issue":"11","key":"10.1016\/j.jacadv.2026.103053_bib27","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1002\/clc.23725","article-title":"Lipid goal attainment in post-acute coronary syndrome patients in China: results from the 6-month real-world dyslipidemia international study II","volume":"44","author":"Gong","year":"2021","journal-title":"Clin Cardiol"},{"issue":"20","key":"10.1016\/j.jacadv.2026.103053_bib28","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1016\/j.jacc.2019.08.010","article-title":"Evolocumab for early reduction of LDL cholesterol levels in patients with acute coronary syndromes (EVOPACS)","volume":"74","author":"Koskinas","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacadv.2026.103053_bib29","first-page":"1","article-title":"Genetic testing for familial hypercholesterolemia: health technology assessment","volume":"22","author":"Ontario","year":"2022","journal-title":"Ont Health Technol Assess Ser"},{"issue":"1","key":"10.1016\/j.jacadv.2026.103053_bib30","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0002-9149(01)02154-3","article-title":"Usefulness of lipoprotein changes during acute coronary syndromes for predicting postdischarge lipoprotein levels","volume":"89","author":"Henkin","year":"2002","journal-title":"Am J Cardiol"},{"issue":"5","key":"10.1016\/j.jacadv.2026.103053_bib31","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.jacl.2023.08.007","article-title":"Impact of providing genetics-based future cardiovascular risk on LDL-C in patients with familial hypercholesterolemia","volume":"17","author":"Nomura","year":"2023","journal-title":"J Clin Lipidol"},{"key":"10.1016\/j.jacadv.2026.103053_bib32","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/j.cjco.2022.03.003","article-title":"Real-World insights into evolocumab use in patients with hyperlipidemia: canadian analysis from the ZERBINI study","volume":"4","author":"Gupta","year":"2022","journal-title":"CJC Open"},{"issue":"1","key":"10.1016\/j.jacadv.2026.103053_bib33","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.49664","article-title":"Opportunistic genomic screening for familial hypercholesterolemia to improve LDL-C","volume":"9","author":"Vassy","year":"2026","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.jacadv.2026.103053_bib34","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.atherosclerosis.2017.12.011","article-title":"High levels of lipoprotein (a) and premature acute coronary syndrome","volume":"269","author":"Rallidis","year":"2018","journal-title":"Atherosclerosis"}],"container-title":["JACC: Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26004746?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772963X26004746?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:26:43Z","timestamp":1792020403000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772963X26004746"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":34,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2772963X26004746"],"URL":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.103053","relation":{},"ISSN":["2772-963X"],"issn-type":[{"value":"2772-963X","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opportunistic Genetic Testing for Familial Hypercholesterolemia in Premature Acute Coronary Syndrome","name":"articletitle","label":"Article Title"},{"value":"JACC: Advances","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacadv.2026.103053","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}],"article-number":"103053"}}